Science Explorer Back to mapMap
Discussion
Researcher · Southern Research Institute · United States

Wenyan Lü

Wenyan Lü publishes mostly in Molecular Biology, Physiology and Oncology, on topics such as Wnt/β-catenin signaling in development and cancer, Alzheimer's disease research and treatments and Cancer-related gene regulation.

ORCID 0009-0007-9803-5162 OpenAlex
World rank
#240,210
of 7,710,434 ranked researchers
Rank in United States
#88,449
of 1,627,098
Works
133
Citations
4.6k
Citations per work
34.4
h-index
38
i10-index 61Top 8.3% in Molecular Biology
Wenyan Lü

What does Wenyan Lü research?

Wenyan Lü's work is mostly in Biochemistry, Genetics and Molecular Biology (38%), Medicine (19%).

Everything else: 57 works · 43.0% of their workLife Sciences: 50 works · 37.9% of their workBiochemistry, Genetics and Molecular Biology: 50 works · 37.9% of their workMolecular Biology: 45 works · 33.7% of their workCell Biology: 6 works · 4.2% of their workHealth Sciences: 25 works · 19.1% of their workMedicine: 25 works · 19.1% of their workOncology: 7 works · 5.6% of their workPhysiology: 7 works · 5.6% of their workCardiology and Cardiovascular Medicine: 6 works · 4.6% of their workPharmacology: 4 works · 3.3% of their workTHEIR WORKWenyan Lü133works
Life Sciences38%Health Sciences19%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else5743.0%
    1. Biochemistry, Genetics and Molecular Biology5037.9%
    1. Medicine2519.1%
  1. 1Molecular Biology34% of their works
  2. 2Physiology6% of their works
  3. 3Oncology6% of their works
  4. 4Cardiology and Cardiovascular Medicine5% of their works
  5. 5Cell Biology4% of their works
  6. 6Pharmacology3% of their works

Research topics

Which keywords describe Wenyan Lü's research?

The keywords of their largest research topics: Cancer, Therapeutic Targets, Wnt Signaling, ß-Catenin, Oxidative Stress, Amyloid Hypothesis, Tau Pathology and Angiogenesis.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Cancer423 topics
  2. Therapeutic Targets312 topics
  3. Wnt Signaling261 topic
  4. ß-Catenin261 topic
  5. Oxidative Stress172 topics
  6. Amyloid Hypothesis121 topic
  7. Tau Pathology121 topic
  8. Angiogenesis112 topics
  9. Arginine Methylation111 topic
  10. Protein Arginine Methyltransferases111 topic
  11. Fibroblast Activation Protein61 topic
  12. Tumor Microenvironment61 topic
  13. Cyclic Nucleotide Phosphodiesterases51 topic
  14. DNA Methylation51 topic
  15. Endoplasmic Reticulum51 topic
  16. Galectins51 topic
  17. Histone Modification51 topic
  18. Immune Regulation51 topic
  19. Stress51 topic
  20. cAMP Signaling51 topic

Where does Wenyan Lü work?

Wenyan Lü's main affiliation in the publication record is Southern Research Institute, United States.

How many publications and citations does Wenyan Lü have?

OpenAlex counts 133 works and 4,576 citations for Wenyan Lü, an h-index of 38, ranking #240,210 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Other researchers named Wenyan Lü

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Wenyan Lü. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.